powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1316346430
Vishisht Mehta
MD
Pulmonary Disease
Las Vegas,
NV
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
14
By payment type
Food and Beverage
$1K
Consulting Fee
$450
Top paying entities
Food and Beverage
$1K
Consulting Fee
$450
QUALITY · MIPS · 2024
Final MIPS score
80.8
Quality
57.1
Cost
63.1
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.25%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
773
Beneficiaries
—
Total drug cost
$339K
Distinct drugs
15
Brand share
79.6%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter
199 claims
Albuterol Sulfate
137 claims
Fluticasone/Vilanterol
64 claims
Prednisone
63 claims
Budesonide/Glycopyr/Formoterol
43 claims
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 290039
Hospital
CCN 290041
Hospital
CCN 290047
Hospital
CCN 290054
Hospital
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,478
Unique beneficiaries
—
Total services
3,629
Distinct HCPCS
22
Medicare payment
$218K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 63 Pulmonary Disease providers in NV — top quintile (cohort median 1,252).